Tarsus Pharmaceuticals
TARS
TARS
162 hedge funds and large institutions have $1.43B invested in Tarsus Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 58 increasing their positions, 42 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% more capital invested
Capital invested by funds: $1.09B → $1.43B (+$338M)
9% more funds holding
Funds holding: 148 → 162 (+14)
8.01% more ownership
Funds ownership: 106.05% → 114.07% (+8%)
Holders
162
Holding in Top 10
8
Calls
$17.5M
Puts
$135K
Top Buyers
| 1 | +$23M | |
| 2 | +$16.1M | |
| 3 | +$13.8M | |
| 4 |
Morgan Stanley
New York
|
+$10.7M |
| 5 |
ABG
Ally Bridge Group
New York
|
+$10.6M |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$10.7M | |
| 3 | -$9.91M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$8.04M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
-$7.07M |